Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Alector and GSK Report Collaboration in Immuno Neurology
Alector, Inc. (NASDAQ: ALEC) has reported a strategic global collaboration to develop and commercialize two clinical stage, potential first in class monoclonal antibodies (AL001 and AL101) to elevate progranulin...